Forte Biosciences Inc.

NASDAQ: FBRX · Real-Time Price · USD
11.85
1.03 (9.52%)
At close: Aug 15, 2025, 3:59 PM
11.61
-2.03%
After-hours: Aug 15, 2025, 04:53 PM EDT

Forte Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
39K 9K n/a 36K
Gross Profit
n/a -9K n/a -36K
Operating Income
-36.6M -32.49M -13.9M -21.49M
Interest Income
1.31M 1.12M n/a n/a
Pretax Income
-35.48M -31.48M -13.88M -21.71M
Net Income
-35.48M -31.48M -13.86M -21.71M
Selling & General & Admin
15.41M 10.62M 8.3M 7.63M
Research & Development
20.71M 21.86M 5.59M 13.85M
Other Expenses
479K -0.00 17K n/a
Operating Expenses
36.6M 32.48M 13.9M 21.49M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a -9K n/a n/a
Cost & Expenses
-36.6M 32.49M 13.9M 21.49M
Income Tax Expense
n/a n/a -17K -200.56K
Shares Outstanding (Basic)
2.92M 1.26M 695.34K 558.71K
Shares Outstanding (Diluted)
2.92M 1.26M 695.34K 558.71K
EPS (Basic)
-12.17 -24.92 -19.96 -38.85
EPS (Diluted)
-12.17 -24.92 -19.96 -38.85
EBITDA
-35.44M -32.48M -13.9M -21.45M
EBIT
-35.48M -32.49M -13.9M -21.49M
Depreciation & Amortization
39K 9K 36K 36K